MicroRNA-145 promotes the phenotype of human glioblastoma cells selected for invasion

Anticancer Research

Volumn 35, Issue 6, 2015, Pages 3209-3216

  Koo, Sunwoo ^a   Martin, Gail ^b   Toussaint, L Gerard ^a,c  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c The Texas Brain and Spine Institute   (United States)

Author keywords

Glioblastoma; MiRNA 145; SLIT ROBO; SrGAP

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; LIPOFECTAMINE; MICRORNA 145; PROTEIN; RHO GTPASE ACTIVATING PROTEIN 1; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MICRORNA; MIRN145 MICRORNA, HUMAN; SRGAP1 PROTEIN, HUMAN;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BRAIN TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GTPASE-ACTIVATING PROTEINS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS;

EID: 84931408125     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA and Cavenee WK: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710, 2007.
2. Giese A, Bjerkvig R, Berens ME and Westphal M: Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21: 1624-1636, 2003.
3. Werbowetski-Ogilvie TE, Seyed Sadr M, Jabado N, Angers-Loustau A, Agar NY, Wu J, Bjerkvig R, Antel JP, Faury D, Rao Y and Del Maestro RF: Inhibition of medulloblastoma cell invasion by Slit. Oncogene 25: 5103-5112, 2006.
4. Wong K, Ren XR, Huang YZ, Xie Y, Liu G, Saito H, Tang H, Wen L, Brady-Kalnay SM, Mei L, Wu JY, Xiong WC and Rao Y: Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 107: 209-221, 2001.
5. Mertsch S, Schmitz N, Jeibmann A, Geng JG, Paulus W and Senner V: Slit2 involvement in glioma cell migration is mediated by Robo1 receptor. J Neurooncol 87: 1-7, 2008.
6. Yiin JJ, Hu B, Jarzynka MJ, Feng H, Liu KW, Wu JY, Ma HI and Cheng SY: Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. Neuro Oncol 11: 779-789, 2009.
7. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
8. Lawler S and Chiocca EA: Emerging functions of microRNAs in glioblastoma. J Neurooncol 92: 297-306, 2009.
9. Karsy M, Arslan E and Moy F: Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme. Genes Cancer 3: 3-15, 2012.
10. Koo S, Martin GS, Schulz KJ, Ronck M and Toussaint LG: Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines. BMC Cancer 12: 143, 2012.
11. Olson EN and Nordheim A: Linking actin dynamics and gene transcription to drive cellular motile functions. Nature reviews Molecular cell biology 11: 353-365, 2010.
12. Zhang HY, Zheng SJ, Zhao JH, Zhao W, Zheng LF, Zhao D, Li JM, Zhang XF, Chen ZB and Yi XN: MicroRNAs 144, 145, and 214 are down-regulated in primary neurons responding to sciatic nerve transection. Brain research 1383: 62-70, 2011.
13. Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A and Raponi M: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 9: 374, 2009.
14. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E and Hahn SA: MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26: 4442-4452, 2007.
15. Xu N, Papagiannakopoulos T, Pan G, Thomson JA and Kosik KS: MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137: 647-658, 2009.
16. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K and Mo YY: p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106: 3207-3212, 2009.
17. Sachdeva M and Mo YY: MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 70: 378-387, 2010.
18. Kent OA, Chivukula RR, Mullendore M, Wentzel EA, Feldmann G, Lee KH, Liu S, Leach SD, Maitra A and Mendell JT: Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev 24: 2754-2759, 2010.
19. Lee HK, Bier A, Cazacu S, Finniss S, Xiang C, Twito H, Poisson LM, Mikkelsen T, Slavin S, Jacoby E, Yalon M, Toren A, Rempel SA and Brodie C: MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor. PLoS One 8: e54652, 2013.
20. Grey F, Tirabassi R, Meyers H, Wu G, McWeeney S, Hook L and Nelson JA: A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs. PLoS Pathog 6: e1000967, 2010.
21. Fang X, Yoon JG, Li L, Yu W, Shao J, Hua D, Zheng S, Hood L, Goodlett DR, Foltz G and Lin B: The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics 12: 11, 2011.